A prognostic rule for elderly patients admitted with community-acquired pneumonia.

BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax (2001) 4.68

Severity prediction rules in community acquired pneumonia: a validation study. Thorax (2000) 2.14

Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax (2004) 1.68

Epidemiology and management of common pulmonary diseases in older persons. J Gerontol A Biol Sci Med Sci (2012) 0.95

Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years. Appl Health Econ Health Policy (2013) 0.95

Management of community-acquired pneumonia in older adults. Ther Adv Infect Dis (2014) 0.89

Prognosis of primary care patients aged 80 years and older with lower respiratory tract infection. Br J Gen Pract (2009) 0.88

Quality of care in elder emergency department patients with pneumonia: a prospective cohort study. BMC Emerg Med (2008) 0.83

Evaluation of pneumonia severity and acute physiology scores to predict ICU admission and mortality in patients hospitalized for influenza. PLoS One (2010) 0.80

A prognostic rule for elderly patients admitted with community-acquired pneumonia. Am J Med (2000) 0.75

Clinical features of spinal infection in individuals older than eighty years. Int Orthop (2011) 0.75

Prognostic implications of aspiration pneumonia in patients with community acquired pneumonia: A systematic review with meta-analysis. Sci Rep (2016) 0.75

Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study. BMC Geriatr (2017) 0.75

Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA (1997) 5.85

Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology (2006) 5.67

Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med (2001) 5.55

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med (1998) 5.06

Mechanisms of epithelial cell-cell adhesion and cell compaction revealed by high-resolution tracking of E-cadherin-green fluorescent protein. J Cell Biol (1998) 5.03

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med (1998) 4.65

Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med (2001) 3.60

Glycogen storage disease in adults. Ann Intern Med (1994) 3.58

New paths in human cancer serology. J Exp Med (1998) 3.12

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc Natl Acad Sci U S A (2000) 3.00

Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease. J Pediatr (2006) 2.97

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer (2001) 2.95

Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med (1998) 2.91

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc Natl Acad Sci U S A (2000) 2.79

Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J (2000) 2.71

Factors affecting synthesis of ascorbic acid in cress seedlings. 2. Ascorbic acid synthesis in relation to sugar formation. Biochem J (1949) 2.46

Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events. Int J Cancer (1999) 2.26

Microstructural fingerprints of phase transitions in shock-loaded iron. Sci Rep (2013) 2.17

Reliability of reported sunburn history in a case-control study of cutaneous malignant melanoma. Am J Epidemiol (1995) 2.05

Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A (1987) 2.05

Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc Natl Acad Sci U S A (2000) 2.02

Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998. Virus Res (2000) 1.95

Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer (1999) 1.91

Cornstarch therapy in type I glycogen-storage disease. N Engl J Med (1984) 1.88

Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II. Mol Ther (2005) 1.87

A mouse mutant p53 product recognized by CD4+ and CD8+ T cells. Proc Natl Acad Sci U S A (1994) 1.86

Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: results from the Cooperative Cardiovascular Project. J Am Coll Cardiol (2001) 1.83

Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer (1998) 1.82

Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am J Physiol Endocrinol Metab (2002) 1.82

Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure. Am J Cardiol (2000) 1.81

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL. J Immunol (2000) 1.76

Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma. Proc Natl Acad Sci U S A (1995) 1.75

Community-acquired bacterial meningitis in adults: categorization of causes and timing of death. Clin Infect Dis (2001) 1.74

Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7. Int J Cancer (2001) 1.71

Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer Immun (2001) 1.69

Comparing AMI mortality among hospitals in patients 65 years of age and older: evaluating methods of risk adjustment. Circulation (1999) 1.69

Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. J Exp Med (2000) 1.67

Quality of care for patients hospitalized with heart failure at academic medical centers. Am Heart J (1999) 1.65

Human glycogen debranching enzyme gene (AGL): complete structural organization and characterization of the 5' flanking region. Genomics (1996) 1.63

Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequence and role of encapsulation. J Clin Invest (1986) 1.63

Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? J Hepatol (2006) 1.62

Expression of MAGE-antigens in normal tissues and cancer. Int J Cancer (2000) 1.60

SSX: a multigene family with several members transcribed in normal testis and human cancer. Int J Cancer (1997) 1.60

Nuclear-cytoplasmic transport and VAI RNA-independent translation of influenza viral messenger RNAs in late adenovirus-infected cells. Cell (1984) 1.57

Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors. Am J Surg Pathol (1998) 1.55

Increased prevalence of Listeria monocytogenes in the faeces of patients receiving long-term H2-antagonists. Eur J Gastroenterol Hepatol (1996) 1.52

Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. Am J Hum Genet (1993) 1.52

Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease: results from a quality improvement project. JAMA (2001) 1.51

A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol (1998) 1.51

Lack of evidence for an association between alpha-adducin and blood pressure regulation in Asian populations. Am J Hypertens (2000) 1.51

Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J Immunol (1998) 1.50

Genome-wide association study of bipolar I disorder in the Han Chinese population. Mol Psychiatry (2010) 1.49

Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction. Arch Intern Med (2001) 1.48

Variations in and correlates of length of stay in academic hospitals among patients with heart failure resulting from systolic dysfunction. Am J Manag Care (1999) 1.47

Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase. Proc Natl Acad Sci U S A (1999) 1.46

Improved fluorescence and dual color detection with enhanced blue and green variants of the green fluorescent protein. J Biol Chem (1998) 1.43

The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet (1999) 1.42

CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis. Int J Cancer (2000) 1.42

Structural analysis of TL genes of the mouse. Proc Natl Acad Sci U S A (1985) 1.41

Direct and regulated interaction of integrin alphaEbeta7 with E-cadherin. J Cell Biol (1998) 1.40

Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest (1996) 1.40

Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res (2001) 1.39

Glycogen storage disease types I and II: treatment updates. J Inherit Metab Dis (2007) 1.39

Brain abscess in glycogen storage disease type Ib. Acta Paediatr Scand (1991) 1.38

Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proc Natl Acad Sci U S A (2000) 1.36

Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia. Gene Ther (2006) 1.35

Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail. J Clin Invest (1998) 1.34

Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. Br J Cancer (2000) 1.34

Warfarin use following ischemic stroke among Medicare patients with atrial fibrillation. Arch Intern Med (1998) 1.33

Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr (1999) 1.30

Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9. Cancer Lett (2000) 1.30

A gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic. Am J Hum Genet (1998) 1.28

Preservation of the thin distal urethra in hypospadias repair. J Urol (2000) 1.27

Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3. Cancer Res (1998) 1.27

Purification of acetylcholinesterase by affinity chromatography and determination of active site stoichiometry. J Biol Chem (1972) 1.26

The incidence of coronary artery disease in patients with symptomatic bradyarrhythmias. Jpn Heart J (2001) 1.25

Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med (1992) 1.25

Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies. Int J Cancer (1998) 1.25

Expression of SSX genes in human tumors. Int J Cancer (1998) 1.24

Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene. J Clin Invest (1996) 1.24

Serological cloning of a melanocyte rab guanosine 5'-triphosphate-binding protein and a chromosome condensation protein from a melanoma complementary DNA library. Cancer Res (2000) 1.23

Assignment of the human glycogen debrancher gene to chromosome 1p21. Genomics (1992) 1.22

Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr (1990) 1.22

Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders. J Inherit Metab Dis (2000) 1.22

R1193Q of SCN5A, a Brugada and long QT mutation, is a common polymorphism in Han Chinese. J Med Genet (2005) 1.21

Mutations in the glucose-6-phosphatase gene are associated with glycogen storage disease types 1a and 1aSP but not 1b and 1c. J Clin Invest (1995) 1.20

High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease. Proc Natl Acad Sci U S A (1996) 1.18

Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Am J Pathol (1996) 1.17

Molecular characterization of glycogen storage disease type III. Curr Mol Med (2002) 1.17

Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade. Cancer Res (2001) 1.15

Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of Pompe disease. Anal Biochem (2000) 1.15

Reduction in oocyte number following prenatal exposure to a diet high in galactose. Science (1981) 1.14

Long-term efficacy after [E1-, polymerase-] adenovirus-mediated transfer of human acid-alpha-glucosidase gene into glycogen storage disease type II knockout mice. Hum Gene Ther (2001) 1.14

Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene. Cancer Res (1999) 1.13

Potent induction of long-term CD8+ T cell memory by short-term IL-4 exposure during T cell receptor stimulation. Proc Natl Acad Sci U S A (2000) 1.11

Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol (1998) 1.11

Electrocardiographic response to enzyme replacement therapy for Pompe disease. Genet Med (2006) 1.10

5'-structural analysis of genes encoding polymorphic antigens of chemically induced tumors. Proc Natl Acad Sci U S A (1987) 1.10

Differences in cervical cancer mortality among black and white women. Obstet Gynecol (1999) 1.10

Alveolar echinococcosis: Em2plus-ELISA and Em18-western blots for follow-up after treatment with albendazole. Trans R Soc Trop Med Hyg (1997) 1.10